14-3-3ζ Overexpression is Associated with Poor Prognosis in Ovarian Cancer.

Hyun-Jung KimSun Hee SungChan Young KimMoon Kyoung BaeMin Sun ChoYun Hwan KimSeung Cheol KimWoong Ju

Published in: Yonsei medical journal (2018)

14-3-3ζoverexpression might be a potential prognostic biomarker for ovarian cancer, and the inhibition of 14-3-3ζcould be a therapeutic option that enhances the antitumor activity of cisplatin.

Keyphrases

poor prognosis
long non coding rna
cell proliferation
transcription factor
human health
risk assessment